Impact Factor Collection
European Journal of Endocrinology has achieved a 2021 Journal Impact FactorTM of 6.558, and has seen a significant increase in its Five-Year Impact Factor from 6.341 to 6.805.
EJE is now ranked 27 out of 146 journals in the ‘Endocrinology and Metabolism’ category of the latest Journal Citation ReportsTM, cementing its place as the leading broad-scoped, clinical and translational endocrinology journal.
We would like to thank all of the authors, reviewers, readers, and our world-class Editors who have helped to make EJE a world-leading authority on all areas of clinical endocrinology. Special thanks go to our Editor-in-Chief, Professor Wiebke Arlt, whose commitment and focus on high-quality, high-impact research from established and emerging areas of clinical endocrinology continues to help the journal grow and make a difference in the endocrinology community.
We are also proud to announce that EJE’s sister journal, Endocrine Connections, received an Impact Factor of 3.221.
Explore the following collection of the top-cited research articles and reviews from 2021.
2021’S TOP CITED RESEARCH:
Thyrotoxicosis in patients with COVID-19: the THYRCOV study
Andrea Lania et al.
Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis
L T van Hulsteijn et al.
Abiraterone acetate treatment lowers 11-oxygenated androgens
Connor Wright et al.
Carotid body chemosensitivity: early biomarker of dysmetabolism in humans
João P Cunha-Guimaraes et al.
Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality
Daniela Esposito et al.
2021’S TOP CITED REVIEWS:
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19
John P Bilezikian et al.
Management of Endocrine Disease: Osteogenesis imperfecta: an update on clinical features and therapies
Ronit Marom, Brien M Rabenhorst, and Roy Morello
GENETICS IN ENDOCRINOLOGY Glucocorticoid resistance syndrome
Géraldine Vitellius and Marc Lombes
GENETICS IN ENDOCRINOLOGY Genetic etiologies of central precocious puberty and the role of imprinted genes
Stephanie A Roberts and Ursula B Kaiser
MANAGEMENT OF ENDOCRINE DISEASE Does gender matter in the management of acromegaly?
Nèle F Lenders, Ann I McCormack, and Ken K Y Ho
MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity
C Poitou, H Mosbah, and K Clément
MANAGEMENT OF ENDOCRINE DISEASE: Female sexual dysfunction for the endocrinologist
E Carosa, A Sansone, and E A Jannini
2021’S TOP CITED CONSENSUS STATEMENTS AND CLINICAL PRACTICE GUIDELINES:
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
Wiebke Arlt et al.
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism
Kristien Boelaert et al.
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
John Newell-Price et al.
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of pituitary tumours
Maria Fleseriu, Olaf M Dekkers, and Niki Karavitaki
ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus
Shakila Thangaratinam et al.
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
Alexis Vrachimis et al.
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemi
Mirjam Christ-Crain et al.